E-LIB Suche - Ergebnisse für: Fleming, Shaun

1

Low-intensity venetoclax-based salvage as a bridge to allog..:

Ashby, Michael ; Fleming, Shaun ; Teh, Tse-Chieh...
Leukemia Research. 136 (2024) - p. 107429 , 2024

Link: https://doi.org/10.1016/..

2

How comparable are patient outcomes in the "real-world" wit..:

Tiong, Ing Soo ; Wall, Meaghan ; Bajel, Ashish...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

P494: A FIRST-IN-HUMAN STUDY OF CD123 NK CELL ENGAGER SAR44..:

Selwyn Stein, Anthony ; Jongen-Lavrencic, Mojca ; Garciaz, Sylvain...
HemaSphere. 7 (2023) S3 - p. e66387cd , 2023

Link: https://doi.org/10.1097/..

4

Animate monitoring is not uniform: implications for the ani..:

Loucks, Jeff ; Reise, Berit ; Gahite, Rosselle.
Frontiers in Psychology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

AML-370 Phase IB OMNIVERSE Trial: Safety and Tolerability o..:

Fleming, Shaun ; Roboz, Gail J. ; Fathi, Amir T....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S293 , 2023

Link: https://doi.org/10.1016/..

6

P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR..:

Marconi, Giovanni ; Arslan, Shukaib ; Fleming, Shaun...
HemaSphere. 7 (2023) S3 - p. e80196f1 , 2023

Link: https://doi.org/10.1097/..

7

TP53 status and impact on AML prognosis within the ELN 2022..:

Fleming, Shaun ; Tsai, Xavier Cheng-Hong ; Morris, Rhiannon..
Blood. 142 (2023) 23 - p. 2029-2033 , 2023

Link: https://doi.org/10.1182/..

8

P567: PHASE 1B OMNIVERSE TRIAL: SAFETY AND TOLERABILITY OF ..:

Fleming, Shaun ; Roboz, Gail ; T. Fathi, Amir...
HemaSphere. 7 (2023) S3 - p. e27202d1 , 2023

Link: https://doi.org/10.1097/..

9

P365: SEQUENTIAL BLINATUMOMAB WITH REDUCED INTENSITY CHEMOT..:

Fleming, Shaun ; Reynolds, John ; Bajel, Ashish...
HemaSphere. 7 (2023) S3 - p. e811479d , 2023

Link: https://doi.org/10.1097/..

10

Phase Ib study of sabatolimab (MBG453), a novel immunothera..:

Brunner, Andrew M. ; Esteve, Jordi ; Porkka, Kimmo...
American Journal of Hematology. 99 (2023) 2 - p. , 2023

Link: https://doi.org/10.1002/..

11

Peripheral Blood CD34 Donor Chimerism has Greater Clinical ..:

Das, Tongted P. ; North, Daniel ; Fleming, Shaun A....
Transplantation and Cellular Therapy. 29 (2023) 7 - p. 454.e1-454.e8 , 2023

Link: https://doi.org/10.1016/..

12

CT-526 Updated Results From a Rapcabtagene Autoleucel (YTB3..:

Shah, Nirav N. ; Flinn, Ian ; Kwon, Mi...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S532-S533 , 2023

Link: https://doi.org/10.1016/..

13

POSTER: AML-370 Phase IB OMNIVERSE Trial: Safety and Tolera..:

Fleming, Shaun ; Roboz, Gail J. ; Fathi, Amir T....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S168 , 2023

Link: https://doi.org/10.1016/..

14

POSTER: CT-526 Updated Results From a Rapcabtagene Autoleuc..:

Shah, Nirav N. ; Flinn, Ian ; Kwon, Mi...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S235 , 2023

Link: https://doi.org/10.1016/..

15

The Utility of Euroflow MRD Assessment in Real-World Multip..:

Turner, Rose ; Kalff, Anna ; Bergin, Krystal...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..